Ivermectin 'Safe' and 'Effective' for Treating Omicron: Japanese Company

A Japanese conglomerate has found that anti-parasitic drug Ivermectin is effective and safe for the treatment of the COVID-19 Omicron variant according to a phase III clinical trial.

Related Keywords

Japan ,Tokyo ,New Hampshire ,United States ,Kitasato ,Japan General ,Brazil ,Japanese ,Americans ,Brazilian ,Leah Cushman ,David Levine ,Paul Marik ,Kitasato University ,Hitchcock Medical Center ,Eastern Virginia Medical School ,World Health Organization ,Critical Care Alliance ,Drug Administration ,Kowa Co ,Information Act ,Epoch Times ,Dartmouth Hitchcock Medical Center ,Front Line ,Care Alliance ,Clinical Trials ,Ivermectin ,Ivermectin For Covid ,The Epoch Times ,